Pablo Eduardo Sigala casillas

Recommended Articles

• What is Traumatic Cataract?

  Perhaps the most poorly recognized key health challenge today is trauma. In the developed world, trauma causes monocular blindness. Ocular injury otiology may vary from one urban area to another and therefore needs careful investigation. Any approach for preventing trauma requires familiarity with...

• Bedroom Talk: Sex, Erectile Dysfunction, and Parkinson's Disease

  Sex, one of the many natural aspects of human behavior, involves passion, immense trust, and great vulnerability as people find themselves sharing a close and physically intimate moment with another person. It offers a brief moment of liberation from the often time dull reality or for some, a way...

• Organizations That Participate in Ovarian Cancer Research

  Ovarian cancer is one of the deadliest cancers affecting women today. Out of all cancers of the reproductive system, it’s the one most likely to end in fatality. About 1 out of 75 women will be diagnosed with ovarian cancer during her lifetime, and 1 out of 100 will die from the disease. With just...

• Treatment for Mumps

  Mumps is a highly contagious viral infection. It usually attacks the parotid glands but sometimes, it can affect other parts of the body. Mumps is common in young children, but can develop at any age. The causative virus for mumps is known as paramyxoviruses. It’s spread through contact with...

• Cold vs. Allergy: How to Tell the Difference

  It is very common to assume that anyone with the sniffles is contagious. Very often, however, those sniffles are not linked to anything contagious at all--they can be related to other factors. The first thought of many individuals when they suffer from a runny nose, nasal congestion, coughing, or...

• Sarepta Sheds Light on Next Generation Drug for Muscular Dystrophy Patients

  Each company has faced its own set of issues, with Sarepta being one of many that are trying to make amends for some issues that have happened in the past. Although there happened to be some issues with the data that was coming from Sarepta, their approval of the drug that can assist with muscular...